Healthcare / Medical DistributionStockholm
$23.98
+0.10 (+0.42%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $838.0M · quality 59.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
32/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$6.5B
P/E
18.6x
↓EV/EBITDA
3694.7x
↑ROE
4.5%
↑Gross Margin
42.6%
↓Debt/Equity
0.72
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+3.3%
FCF CAGR
+256.8%
FCF margin
6.6%
FCF / Net income
2.18x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $11.00B · net income $334.0M · FCF $727.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $11.00B | $11.00B | $11.29B | $10.98B | $9.98B |
| Net Income | $334.0M | $334.0M | $498.0M | $480.0M | $449.0M |
| EBITDA | $1.77B | $1.77B | $2.01B | $1.96B | $1.70B |
| EPS | 1.23 | 1.23 | 1.83 | 1.76 | 1.65 |
| Gross Margin | 42.6% | 42.6% | 43.4% | 43.1% | 41.9% |
| Operating Margin | 7.6% | 7.6% | 9.1% | 9.0% | 8.0% |
| Net Margin | 3.0% | 3.0% | 4.4% | 4.4% | 4.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.72 | 0.72 | 0.65 | 0.72 | 0.85 |
| Current Ratio | 1.08 | 1.08 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $727.0M | $727.0M | $838.0M | $1.38B | $16.0M |
| Returns | |||||
| ROE | 4.5% | 4.5% | 6.0% | 6.3% | 6.0% |
| Valuation | |||||
| P/E | 18.59 | 18.59 | 19.84 | 22.26 | 23.90 |
| EV/EBITDA | 3694.71 | 3694.71 | 7.16 | 7.77 | 9.48 |
| P/B | 875.88 | 875.88 | 1.19 | 1.41 | 1.45 |
| Growth & Yield | |||||
| Revenue Growth | -2.6% | -2.6% | 2.8% | 10.0% | — |
| EPS Growth | -32.8% | -32.8% | 4.0% | 6.7% | — |
| Dividend Yield | 4.0% | 4.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
20.0%
EPS terminal req.
$2.13
Spread vs growth
-52.8%
5Y implied EPS CAGR
15.9%
EPS terminal req.
$2.57
Spread vs growth
-48.7%
10Y implied EPS CAGR
12.9%
EPS terminal req.
$4.15
Spread vs growth
-45.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-14.8%
Start / end P/E
16.1x → 19.5x
EPS bridge
1.83 → 1.23
Residual
-6.8%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.